The WACC of Cymabay Therapeutics Inc (CBAY) is 6.8%.
| Range | Selected | |
| Cost of equity | 5.50% - 8.40% | 6.95% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.4% - 8.2% | 6.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.35 | 0.62 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.50% | 8.40% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.03 | 0.03 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.4% | 8.2% |
| Selected WACC | 6.8% | |